Liver regeneration possible with new drug, eliminating need for a transplant
New drug can help activate liver regeneration and repair in end-stage liver disease
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
New drug can help activate liver regeneration and repair in end-stage liver disease
Scientists fear a resurgence of Covid-19 infections and deaths from antibody resistant BQ.1.1 strain
Scientists have identified 42 genes related to dyslexia
Following a low carb diet lowers blood sugar levels in pre-diabetic people
L'Oreal facing lawsuit for its hair straightening products
USFDA approves Zydus Lifesciences anti-fungal injection HQ Team October 26, 2022: Zydus Lifesciences announced that it had received final approval from the USFDA.
A Fudan University study says that risk of developing dementia is associated with the trajectory of depression in older adults
Pfizer set to increase Covid-19 vaccine prices by almost four times in the US
Booster shots reduce severity of covid in cirrhosis patients
Lupin buys two inhalation brands for $75million
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com